Literature DB >> 9733738

Redesign of choline acetyltransferase specificity by protein engineering.

C N Cronin1.   

Abstract

Since the development of site-directed mutagenesis techniques over 15 years ago (Zoller, M. J., and Smith, M. (1982) Nucleic Acids Res. 10, 6487-6500), it has been a goal of protein engineering to utilize the procedure to redesign existing enzyme structures to produce proteins with altered or novel catalytic properties. To date, however, the more successful achievements have relied exclusively on the availability of three-dimensional protein structure maps to direct the redesign strategies. Presently, such maps are unavailable for choline acetyltransferase and carnitine acetyltransferase, enzymes that catalyze the reversible transfer of an acetyl group from acetyl-CoA to choline and L-carnitine, respectively. A more empirical approach, based on cross-referencing substrate structure comparisons with protein alignment data, was used to redesign choline acetyltransferase to accommodate L-carnitine as an acceptor of the acetyl group. A mutant choline acetyltransferase that incorporates four amino acid substitutions from wild type, shows a substantial increase in catalytic efficiency (kcat/Km) toward L-carnitine (1,620-fold) and shifts the catalytic discrimination between choline and L-carnitine by >390,000 in favor of the latter substrate. These dramatic alterations in catalytic function demonstrate that significant success in protein redesign can be achieved in the absence of three-dimensional protein structure data.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733738     DOI: 10.1074/jbc.273.38.24465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders.

Authors:  Yiying Cai; Ciarán N Cronin; Andrew G Engel; Kinji Ohno; Louis B Hersh; David W Rodgers
Journal:  EMBO J       Date:  2004-05-06       Impact factor: 11.598

2.  Sequencing and functional expression of the malonyl-CoA-sensitive carnitine palmitoyltransferase from Drosophila melanogaster.

Authors:  V N Jackson; J M Cameron; V A Zammit; N T Price
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

3.  Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.

Authors:  K Ohno; A Tsujino; J M Brengman; C M Harper; Z Bajzer; B Udd; R Beyring; S Robb; F J Kirkham; A G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  Quantitative chimeric analysis of six specificity determinants that differentiate Escherichia coli aspartate from tyrosine aminotransferase.

Authors:  Wendy A Shaffer; Tinh N Luong; Steven C Rothman; Jack F Kirsch
Journal:  Protein Sci       Date:  2002-12       Impact factor: 6.725

5.  Therapeutic hypothermia achieves neuroprotection via a decrease in acetylcholine with a concurrent increase in carnitine in the neonatal hypoxia-ischemia.

Authors:  Toshiki Takenouchi; Yuki Sugiura; Takayuki Morikawa; Tsuyoshi Nakanishi; Yoshiko Nagahata; Tadao Sugioka; Kurara Honda; Akiko Kubo; Takako Hishiki; Tomomi Matsuura; Takao Hoshino; Takao Takahashi; Makoto Suematsu; Mayumi Kajimura
Journal:  J Cereb Blood Flow Metab       Date:  2015-01-14       Impact factor: 6.200

Review 6.  In vitro Engineering of Novel Bioactivity in the Natural Enzymes.

Authors:  Vishvanath Tiwari
Journal:  Front Chem       Date:  2016-10-07       Impact factor: 5.221

7.  Overcoming inefficient cellobiose fermentation by cellobiose phosphorylase in the presence of xylose.

Authors:  Kulika Chomvong; Vesna Kordić; Xin Li; Stefan Bauer; Abigail E Gillespie; Suk-Jin Ha; Eun Joong Oh; Jonathan M Galazka; Yong-Su Jin; Jamie H D Cate
Journal:  Biotechnol Biofuels       Date:  2014-06-07       Impact factor: 6.040

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.